On 15^th September, 2022 THSTI and Central Council For Research In Homoeopathy signed an agreement for evaluating the immunological effects of Arsenicum album 30C against SARS-Cov2 Infection as part of RCT titled ‘Immunological responses of Arsenicum album 30C to combat COVID-19: A double-blind, randomized, placebo controlled-clinical trial in the Pathanamthitta district of Kerala.’

Dr. Pramod Kumar Garg, Executive Director, THSTI and Dr. Subhash Kaushik, Director General, CCRH signed the agreement. During the signing ceremony, Dr. Amit Awasthi and his team members, Dr. Shaji Kumar, Scientist IV, CCRH, Dr. Sreekanth G. Pillai, Virologist, Indian Institute of Chemical Technology (IICT), Hyderabad and Dr. Suhana P. Azis, Scientist II, CCRH attended the event.